Alnylam Pharmaceuticals
ALNY
#563
Rank
C$57.30 B
Marketcap
C$432.06
Share price
-1.75%
Change (1 day)
23.68%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company